Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1962 1
1967 2
1970 1
1971 3
1972 2
1973 2
1974 2
1975 9
1976 14
1977 17
1978 26
1979 35
1980 32
1981 31
1982 40
1983 34
1984 44
1985 57
1986 47
1987 52
1988 46
1989 43
1990 57
1991 61
1992 66
1993 65
1994 75
1995 70
1996 75
1997 89
1998 93
1999 104
2000 75
2001 96
2002 86
2003 90
2004 96
2005 115
2006 105
2007 112
2008 112
2009 127
2010 145
2011 128
2012 137
2013 158
2014 163
2015 192
2016 169
2017 203
2018 230
2019 233
2020 249
2021 282
2022 271
2023 255
2024 120

Text availability

Article attribute

Article type

Publication date

Search Results

4,740 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Malignant Hypothalamic Neoplasm"
Page 1
Pituitary adenomas: an overview.
Lake MG, Krook LS, Cruz SV. Lake MG, et al. Am Fam Physician. 2013 Sep 1;88(5):319-27. Am Fam Physician. 2013. PMID: 24010395 Free article. Review.
Small nonfunctioning adenomas and prolactinomas in asymptomatic patients do not require immediate intervention and can be observed....
Small nonfunctioning adenomas and prolactinomas in asymptomatic patients do not require immediate intervention and can be observed... …
Childhood-onset Craniopharyngioma.
Otte A, Müller HL. Otte A, et al. J Clin Endocrinol Metab. 2021 Sep 27;106(10):e3820-e3836. doi: 10.1210/clinem/dgab397. J Clin Endocrinol Metab. 2021. PMID: 34086900 Review.
The treatment of choice in case of favorable tumor location (without hypothalamic involvement) is complete resection. It is important to ensure that optical and hypothalamic functionality are preserved. ...Severe impairment of quality of life and comorbidities such …
The treatment of choice in case of favorable tumor location (without hypothalamic involvement) is complete resection. It is important …
Diagnostic challenges in cyclic Cushing's syndrome: a systematic review.
Nowak E, Vogel F, Albani A, Braun L, Rubinstein G, Zopp S, Ritzel K, Beuschlein F, Theodoropoulou M, Reincke M. Nowak E, et al. Lancet Diabetes Endocrinol. 2023 Aug;11(8):593-606. doi: 10.1016/S2213-8587(23)00150-X. Epub 2023 Jul 7. Lancet Diabetes Endocrinol. 2023. PMID: 37429301 Review.
We compared the clinical symptoms and comorbidities of patients with cyclic Cushing's syndrome with those of patients with non-cyclic Cushing's syndrome and observed no major difference. In adrenocorticotropic hormone (ACTH)-dependent cyclic Cushing's syndrome, bilateral i …
We compared the clinical symptoms and comorbidities of patients with cyclic Cushing's syndrome with those of patients with non-cyclic Cushin …
Clinically non-functioning pituitary adenomas.
Chanson P, Wolf P. Chanson P, et al. Presse Med. 2021 Dec;50(4):104086. doi: 10.1016/j.lpm.2021.104086. Epub 2021 Oct 28. Presse Med. 2021. PMID: 34718111 Review.
NFPA can sometimes recur even after complete resection, but predicting the individual risk of tumor remnant progression is difficult. ...
NFPA can sometimes recur even after complete resection, but predicting the individual risk of tumor remnant progression is difficult. …
Craniopharyngiomas.
Karavitaki N, Cudlip S, Adams CB, Wass JA. Karavitaki N, et al. Endocr Rev. 2006 Jun;27(4):371-97. doi: 10.1210/er.2006-0002. Epub 2006 Mar 16. Endocr Rev. 2006. PMID: 16543382 Review.
This should focus on the prevention of recurrence(s), improvement of survival, reduction of the significant disease and treatment-related morbidity (endocrine, visual, hypothalamic, neurobehavioral, and cognitive), and preservation of the quality of life. ...Apart from the …
This should focus on the prevention of recurrence(s), improvement of survival, reduction of the significant disease and treatment-related mo …
Aggressive pituitary tumors (PitNETs).
Nishioka H. Nishioka H. Endocr J. 2023 Mar 28;70(3):241-248. doi: 10.1507/endocrj.EJ23-0007. Epub 2023 Mar 3. Endocr J. 2023. PMID: 36858483 Free article.
At present, no single morphological or histological marker has been shown as yet to reliably predict their aggressive behavior. In terms of treatment, temozolomide (TMZ) had been considered promising and the sole therapeutic option for aggressive and malignant PitNE …
At present, no single morphological or histological marker has been shown as yet to reliably predict their aggressive behavior. In te …
Craniopharyngioma in childhood.
May JA, Krieger MD, Bowen I, Geffner ME. May JA, et al. Adv Pediatr. 2006;53:183-209. doi: 10.1016/j.yapd.2006.04.013. Adv Pediatr. 2006. PMID: 17089867 Review.
In summary, much progress has been made in our understanding of childhood craniopharyngiomas. These histologically benign but "geographically malignant" tumors are challenging to treat and require experienced clinicians from multiple disciplines including neurosurgery, rad …
In summary, much progress has been made in our understanding of childhood craniopharyngiomas. These histologically benign but "geographicall …
Editorial: Outcome prediction in pituitary adenomas.
Hosseinkhan N, Khamseh ME, Bignami M, Giuliani A. Hosseinkhan N, et al. Front Endocrinol (Lausanne). 2022 Aug 23;13:990374. doi: 10.3389/fendo.2022.990374. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36082071 Free PMC article. No abstract available.
Characteristics and factors influencing hypothalamic pituitary dysfunction in patients with craniopharyngioma.
Guo Y, Pei L, Li Y, Li C, Gui S, Ni M, Liu P, Zhang Y, Zhong L. Guo Y, et al. Front Endocrinol (Lausanne). 2023 Jun 2;14:1180591. doi: 10.3389/fendo.2023.1180591. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37324266 Free PMC article.
The neuroendocrine function of these patients before and after surgery was investigated. The differences in hypothalamic-pituitary function between the ACP and PCP groups were compared. ...More patients experienced adenohypophyseal hypofunction, DI, and hypothalamic …
The neuroendocrine function of these patients before and after surgery was investigated. The differences in hypothalamic-pituitary fu …
Pituitary Tumors: Genetic and Molecular Factors Underlying Pathogenesis and Clinical Behavior.
Spada A, Mantovani G, Lania AG, Treppiedi D, Mangili F, Catalano R, Carosi G, Sala E, Peverelli E. Spada A, et al. Neuroendocrinology. 2022;112(1):15-33. doi: 10.1159/000514862. Epub 2021 Feb 1. Neuroendocrinology. 2022. PMID: 33524974 Free article. Review.
Pituitary neuroendocrine tumors (PitNETs) are the most common intracranial neoplasms. Although generally benign, they can show a clinically aggressive course, with local invasion, recurrences, and resistance to medical treatment. ...Understanding subcellular mechanisms und …
Pituitary neuroendocrine tumors (PitNETs) are the most common intracranial neoplasms. Although generally benign, they can show a clin …
4,740 results